Tags : Tagrisso

AstraZeneca’s Tagrisso (osimertinib) Receives NMPA’s Approval as a 1L Therapy for EGFR-Mutated Non-Small Cell Lung Cancer in China

AstraZeneca’s Tagrisso (osimertinib) Receives NMPA’s Approval as a 1L Therapy

Tuba Khan September 4, 2019

Shots: The NMPA’s approval follows its PR pathway and is based on P-III FLAURA study assessing Tagrisso (80mg, qd) vs EGFR-TKIs (erlotinib [150mg, qd]/gefitinib [250mg, qd]) in 556 previously untreated […]readmore

AstraZeneca Reports Updated Positive Results of Tagrisso (osimertinib) in P-III FLAURA Study for 1L EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca Reports Updated Positive Results of Tagrisso (osimertinib) in P-III

Tuba Khan August 9, 2019

Shots: The P-III FLAURA study involves assessing of Tagrisso (80mg, qd) vs EGFR-TKIs (erlotinib, 50mg, qd /gefitinib, 250mg, qd) in 556 patients with LA/metastatic EGFRm NSCLC across 29 countries In […]readmore

1
2

Copyright © 2020 Digiqole. All Right Reserved.